Remove Article Remove Clinical Practice Remove Insurance Remove Screening
article thumbnail

Pearls profiles: Get to know Neil Baum, MD

Physician's Practice

Today we're introducing Neil Baum, MD, Professor of Clinical Urology at Tulane Medical School in New Orleans, Louisiana, and the author of Marketing Your Clinical Practice-Ethically, Effectively, and Economicall y, which is in its 4th edition, has sold over 175,000 copies and has been translated into Spanish.

article thumbnail

Hearing Loss in Geriatrics and Palliative Care: A Podcast with Nick Reed and Meg Wallhagen

GeriPal

Was there any mention about the impact that hearing loss has in communication or what we should do about it in clinical practice? Screening for addressing hearing loss should be an integral part of what we do in geriatrics and palliative care, but it often is either a passing thought or completely ignored. I’m guessing not.

IT 102
Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

Lung cancer screening in primary care: more pragmatic research needed

Common Sense Family Doctor

The US Preventive Services Task Force , the American Academy of Family Physicians , and the American College of Chest Physicians recommend annual low-dose computed tomography (CT) screening for adults 50 to 80 years of age who have at least a 20 pack-year smoking history and currently smoke or have smoked within the past 15 years.

article thumbnail

Social Risk Burden and Its Impact on Healthcare Use in IBD

Physician's Weekly

High social risk burden in adults with IBD drives emergency care use and medication gaps—spotlighting the urgent need for social screening in clinical practice. A greater social risk burden was linked to increased odds of unplanned healthcare utilization (severe vs none: OR, 3.5 [1.2-10.2])

article thumbnail

Substance Use Disorder in Aging and Serious Illness: A Podcast with Katie Fitzgerald Jones, Jessica Merlin, Devon Check

GeriPal

After discussing screening options for substance use disorder, we go on to talk about both the treatments for it and the issues that arise. We got a couple of articles to discuss and a lot of different components of this. Eric: Which brings us to an article. We’re going to be covering it in both cancer and in aging.

Illness 136
article thumbnail

Psychedelics – reasons for caution: Stacy Fischer, Brian Anderson, Theora Cimino

GeriPal

FDA is considering approval, shifting away from Schedule I restrictions, paving the way for use in clinical practice. Stacy: I honestly read Michael Pollan’s New Yorker article and was really inspired, and cold emailed the group at NYU, and they responded. Alex: So that’s not our prototypical screening ESAS question.